Earnings History Data for Aprea Therapeutics (APRE) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Aprea Therapeutics
Aprea Therapeutics Inc. is a biopharmaceutical company. It is focused on developing and commercializing novel cancer therapeutics which reactivate the mutant tumor suppressor protein, p53. The Company's lead drug candidate, APR-246, a first-in-class small molecule p53 reactivator, is in clinical development for myelodysplastic syndromes, acute myeloid leukemia as well as additional hematologic and solid tumor malignancies. Aprea Therapeutics Inc. is based in Boston, Massachusetts.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26-03-2024 | PM | APRE | Aprea Therapeutics | 23.00 | -0.92 | -0.56 | 0.00 | Aprea Therapeutics GAAP EPS of -$0.92 [3/26/2024 8:05 AM] |
5.94 | -0.14 (-2.36%) |
0.0 | 0.0 (0.00%) |
2.78 - 8.85 | 8,685 | 30,000 | 0 | ||
| 30-03-2023 | PM | APRE | Aprea Therapeutics | 12.00 | -0.92 | -2.60 | 0.00 | Aprea Therapeutics GAAP EPS of -$0.92 beats by $2.30 [3/31/2023 12:49 AM] |
4.44 | -0.16 (-3.50%) |
0.0 | 0.0 (0.00%) |
4.44 - 40.80 | 4,857 | 10,000 | 0 | ||
| 09-11-2022 | AH | APRE | Aprea Therapeutics | 15.00 | -0.12 | -0.28 | 0.00 | Aprea Therapeutics GAAP EPS of -$0.12 misses by $0.03 [11/9/2022 5:22 PM] |
0.4916 | -0.10 (-16.55%) |
0.55 | -0.04 (-7.38%) |
0.49 - 5.22 | 778,659 | 70,000 | 1,150 | ||
| 16-05-2022 | PM | APRE | Aprea Therapeutics | 24.00 | -0.36 | -0.38 | 0.00 | Aprea Therapeutics GAAP EPS of -$0.36 beats by $0.02 [5/16/2022 9:26 AM] |
0.9626 | -0.23 (-19.11%) |
0.0 | 0.0 (0.00%) |
0.96 - 7.80 | 1,108,783 | 240,000 | 0 | ||
| 08-11-2021 | AH | 4:15 PM ET (Nov 8) |
APRE | Aprea Therapeutics | 108.00 | -0.45 | -0.44 | 0.00 | Aprea Therapeutics EPS beats by $0.01 [11/8/2021 5:00 PM] |
5.08 | 0.04 (0.79%) |
5.04 | 0.0 (0.00%) |
3.17 - 30.99 | 946,472 | 990,000 | 18,868 | |
| 12-08-2021 | AH | APRE | Aprea Therapeutics, Inc. | 88.00 | -0.48 | -0.47 | 0.00 | Aprea Therapeutics EPS beats by $0.02 [8/12/2021 5:03 PM] |
3.65 | -0.39 (-9.65%) |
3.74 | -0.30 (-7.43%) |
3.38 - 31.45 | 1,208,658 | 580,000 | 94,843 | ||
| 06-05-2021 | AH | APRE | Aprea Therapeutics, Inc. | 92.00 | -0.46 | -0.52 | 0.00 | Aprea Therapeutics EPS beats by $0.11 [5/6/2021 5:23 PM] |
4.28 | 0.02 (0.47%) |
4.20 | -0.06 (-1.41%) |
4.13 - 41.12 | 381,783 | 330,000 | 8,383 | ||
| 16-03-2021 | AH | APRE | Aprea Therapeutics, Inc. | 126.00 | -0.73 | -0.63 | 0.00 | Aprea Therapeutics EPS misses by $0.10 [3/16/2021 4:51 PM] |
5.91 | -0.24 (-3.90%) |
5.69 | -0.46 (-7.48%) |
4.66 - 41.12 | 935,068 | 729,554 | 35,321 | ||